ABBOTT HEALTHCARE PVT. LTD

Transcription

1 ड प स ओ 2013 क प र 4 क तहत, अगस त 2015 क आ कड क आध ररत, म ल य क स गणन Computation of Ceiling Price based on Aug-2015 Data under Para 4 of DPCO 2013 Number of Companies consisting of Market Share of 1% & Above Diclofenac Injection 25 mg/ml Per ML Sum of MAT value considered for price calculation (in Lakhs) Sum of PTR per unit considered for price calculation Number of s considered 16 Average PTR 1.20 Add : 16% Retailer Margin 0.19 Ceiling Price (without local taxes) 1.39 % Reduction with compared to Highest Price 14.89% WPI Reduction wef % 0.04 Final Ceiling Price (without local taxes) 1.35 Unique Composition as per as NLEM per NLEM Minimum Price 0.66 S.O. 619(E) dated Maximum Price 1.41 Ceiling Price as per NLEM Per ML Average of all considered 1.20 Derived Ceiling PTR 1.41 Ceiling Price 1.39 TOTAL MAT 19,39,45, % Levelwise MAT (ignoring O% MAT) DICLOFENAC M1A12 ESGIPYRIN DS 25 MG INJECTION 3 ML ESGIPYRIN DS ABBOTT HEALTHCARE PVT. LTD 25 MG 3 ML ,39,71, % 17.71% Y DICLOFENAC M1A12 TOPAC 25 MG INJECTION 2 ML TOPAC ABBOTT HEALTHCARE PVT. LTD 25 MG 2 ML ,17, % 17.71% Y DICLOFENAC M1A12 TOPAC IM 25 MG INJECTION 3 ML TOPAC ABBOTT HEALTHCARE PVT. LTD 25 MG 3 ML ,84, % 17.71% Y DICLOFENAC M1A12 ZOBID 25 MG INJECTION 3 ML ZOBID ABBOTT HEALTHCARE PVT. LTD 25 MG 3 ML , % 17.71% Y DICLOFENAC M1A12 POWERFLAM 25 MG INJECTION 3 ML POWERFLAM ALKEM LABORATORIES LTD. 25 MG 3 ML , % 0.02% N DICLOFENAC M1A12 EMERGESIC 25 MG INJECTION 3 ML EMERGESIC ANGLO-FRENCH DRUGS & INDUSTRIES LTD. 25 MG 3 ML , % 0.02% N DICLOFENAC M1A12 BESTODEK 25 MG INJECTION 3 ML BESTODEK BESTOCHEM FORMULATIONS (I) LTD 25 MG 3 ML ,26, % 1.72% Y DICLOFENAC M1A12 VIVOGESIC(BES) 25 MG INJECTION 3 ML VIVOGESIC(BES) BESTOCHEM FORMULATIONS (I) LTD 25 MG 3 ML ,08, % 1.72% Y DICLOFENAC M1A12 DICLOTAL 25 MG INJECTION 3 ML DICLOTAL BLUE CROSS LABORATORIES LTD 25 MG 3 ML ,91,81, % 35.67% Y DICLOFENAC M1A12 LYSOFLAM DIG 25 MG INJECTION 3 ML LYSOFLAM DIG CACHET PHARMACEUTICALS PVT LTD 25 MG 3 ML ,92, % 5.10% Y DICLOFENAC M1A12 DICLOSTAR 25 MG INJECTION 3 ML DICLOSTAR CADILA PHARMACEUTICALS LTD 25 MG 3 ML ,12, % 0.06% N DICLOFENAC M1A12 DOFEC 25 MG INJECTION 3 ML DOFEC DWD PHARMACEUTICALS LTD 25 MG 3 ML , % 0.05% N DICLOFENAC M1A12 OSTEOFLAM 25 MG INJECTION 3 ML OSTEOFLAM INDOCO REMEDIES LTD 25 MG 3 ML ,75, % 0.81% N DICLOFENAC M1A12 NUFENAC 25 MG INJECTION 3 ML NUFENAC KARNATAKA ANTIBIOTICS & PHARMACEUTICALS LTD(KAPL) 25 MG 3 ML ,99, % 0.15% N DICLOFENAC M1A12 VIVIAN 25 MG INJECTION 3 ML VIVIAN LINCOLN PHARMACEUTICALS LTD 25 MG 3 ML ,98, % 2.53% Y DICLOFENAC M1A12 DEFENAC 25 MG INJECTION 3 ML DEFENAC LUPIN LTD 25 MG 3 ML ,61, % 3.93% Y DICLOFENAC M1A12 DICLONAC 25 MG INJECTION 3 ML DICLONAC LUPIN LTD 25 MG 3 ML ,50, % 3.93% Y DICLOFENAC M1A12 DILONA 25 MG INJECTION 3 ML DILONA MAPRA LABORATORIES PVT. LTD 25 MG 3 ML ,67,96, % 18.97% Y DICLOFENAC M1A12 PAIN OFF 25 MG INJECTION 3 ML PAIN OFF MERCURY HEALTH CARE PVT LTD 25 MG 3 ML ,48, % 0.49% N DICLOFENAC M1A12 DIVON 25 MG INJECTION 3 ML DIVON MICRO LABS LTD 25 MG 3 ML , % 0.05% N DICLOFENAC M1A12 JUSTIN 25 MG INJECTION 1 ML JUSTIN NEON LABORATORIES LTD 25 MG 1 ML ,66, % 0.09% N DICLOFENAC M1A12 DILOFEN 25 MG INJECTION 3 ML DILOFEN P &B LABORATORIES PVT LTD 25 MG 3 ML , % 0.01% N DICLOFENAC M1A12 VOLFLAM 25 MG/1ML INJECTION 3 ML VOLFLAM PSYCHOTROPICS INDIA LTD 25 MG 3 ML ,55, % 0.08% N DICLOFENAC M1A12 FENAK 25 MG INJECTION 3 ML FENAK SUN PHARMA (RANBAXY LABORATORIES LTD) 25 MG 3 ML ,20, % 0.27% N DICLOFENAC M1A12 NAC 25 MG INJECTION 3 ML NAC SYSTOPIC LABORATORIES LTD-MEM 25 MG 3 ML , % 0.02% N DICLOFENAC M1A12 DICLOMOL 25 MG INJECTION 3 ML DICLOMOL WIN-MEDICARE PVT. LTD. 25 MG 3 ML ,97, % 2.63% Y DICLOFENAC M1A12 ACTIVA 25 MG INJECTION 3 ML ACTIVA ZYDUS CADILA 25 MG 3 ML ,15, % 9.65% Y DICLOFENAC M1A12 INAC 25 MG INJECTION 3 ML INAC ZYDUS CADILA 25 MG 3 ML ,80,06, % 9.65% Y DICLOFENAC M1A12 VOVCAD(ZYD) 25 MG INJECTION 3 ML VOVCAD(ZYD) ZYDUS CADILA 25 MG 3 ML ,87, % 9.65% Y ( ) Unit Considered

2 Computataion of Retail Price based on Nov., 2015 Data under Para 4 of DPCO 2013 Clobetasol Propionate IP 0.05% w/w + Neomycin Sulphate IP 0.50% w/w + Clorimazole IP 1.00% w/w + Chlorocresol 0.1% IP cream of M/s Pharma Force Labs./ M/s Gem Mankind Number of Companies cosisting of Market Share of 1% & Above 3 Sum of MAT value considered for price calculation (in Lakhs) 1, Sum of PTR per unit considered for price calculation 7.87 Number of s considered 3 Average PTR 2.62 Add : 16% Retailer Margin 0.42 Retail Price (without local taxes) 3.04 % Reduction with compared to Highest Price 19.38% Minimumum Price 1.83 Maximum Price 3.25 Average of all considered 2.62 Retail Price 3.04 S. TOTAL MAT 13,04,48, % Unit PTR MAT SKU wise Price per Unit Considere d 1 CLOP GM NEO CREAM 15 GM CLOP GM NEO ZYDUS CADILA 1/0.05/0.5 %W/W 15 GM ,67,05, % Y CLOSTAR-GM 1/0.05/0.5 %W/W CREAM 16 GM CLOSTAR-GM MANKIND PHARMACEUTICALS LTD. 1/0.05/0.5 %W/W 16 GM ,97,50, % Y CLOTEBATE GM CREAM 10 GM CLOTEBATE GM RANBAXY LABORATORIES LTD 1/0.05/0.5 %W/W 10 GM , % N TRIBEN CN CREAM 15 GM TRIBEN CN JENBURKT PHARMACEUTICALS LTD 1/0.05/0.5 %W/W 15 GM ,60, % Y ZINCORT GC NEO 1/0.05/0.5 % CREAM 15 GM ZINCORT GC NEO MEGHA HEALTHCARE 1/0.05/0.5 %W/W 15 GM ,47, % N 2.49

3 Computataion of Retail Price based on Feb., 2016 Data under Para 4 of DPCO 2013 HUMAN CHORIONIC GONADOTROPIN IU Inj. of M/s Sanzyme (P) Ltd. / M/s Sandoz Pvt. Ltd. Number of Companies cosisting of Market Share of 1% & Above 12 Sum of MAT value considered for price calculation (in Lakhs) 2, Sum of PTR per unit considered for price calculation Number of s considered 16 Average PTR Add : 16% Retailer Margin Retail Price (without local taxes) % Reduction with compared to Highest Price 27.53% TOTAL MAT 20,67,52, % Minimumum Price Maximum Price Average of all considered Retail Price Unit Considered 1 HUCOG HP IU INJECTION 1 HUCOG HP BHARAT SERUMS & VACCINES LTD IU 1 Each Vial ,72,54, % Y OVIPURE HP IU INJECTION 1 OVIPURE HP BHARAT SERUMS & VACCINES LTD IU 1 Each Vial ,62,79, % Y EEMA HP IU INJECTION 1 EEMA HP CORONA IU 1 Each Vial ,60, % Y MATERNA HCG HP IU INJECTION 1 MATERNA HCG HP EMCURE PHARMACEUTICALS LTD IU 1 Each Vial ,16,90, % Y CORIOSURGE XP IU INJECTION 1 ML CORIOSURGE XP INTAS PHARMACEUTICALS LTD IU 1 Each Vial ,57,16, % Y LUPI-HCG IU INJECTION 1 LUPI-HCG LUPIN LTD IU 1 Each Vial ,52,68, % Y EUTRIG HP IU INJECTION 1 EUTRIG HP SAMARTH LIFE SCIENCES PVT LTD IU 1 Each Vial ,36,71, % Y PUBERGEN IU INJECTION 1 PUBERGEN SANZYME LTD IU 1 Each Vial ,09, % Y SIFASI HP IU INJECTION 10 ML SIFASI HP SERUM INSTITUTE OF INDIA LTD IU 1 Each Vial ,17,79, % Y FERTIGYN IU INJECTION 1 FERTIGYN SUN PHARMA LABORATORIES LTD IU 1 Each Vial ,63, % Y FERTIGYN HP IU INJECTION 1 FERTIGYN HP SUN PHARMA LABORATORIES LTD IU 1 Each Vial ,51,81, % Y CHORIOTEC IU INJECTION 1 CHORIOTEC UNITED BIOTECH (P) LTD IU 1 Each Vial , % N OVUTRIG HP IU INJECTION 1 ML OVUTRIG HP VHB LIFE SCIENCES INC IU 1 Each Vial ,01, % Y CORION IU INJECTION 1 ML CORION WIN-MEDICARE PVT. LTD IU 1 Each Vial ,23, % Y OVIDAC IU INJECTION 1 ML OVIDAC ZYDUS CADILA IU 1 Each Vial ,31, % Y ZYHCG IU INJECTION 1 ZYHCG ZYDUS CADILA IU 1 Each Vial ,53, % Y ZYHCG HP IU INJECTION 1 ZYHCG HP ZYDUS CADILA IU 1 Each Vial ,84, % Y Rs. Per Vial Worked out Retail Price Claimed Retail Price Already notified Retail Price - Proposed Retail Price

4 Computataion of Retail Price based on Feb., 2016 Data under Para 4 of DPCO 2013 IRON 100mg + FOLIC ACID 1500mcg+ ZINC 22.5mg of M/s Indu Drugs Pvt. Ltd./M/s Nutrinova Life Sciences Pvt. Ltd. Number of Companies cosisting of Market Share of 1% & Above 9 Sum of MAT value considered for price calculation (in Lakhs) 2, Sum of PTR per unit considered for price calculation Number of s considered 9 Average PTR 6.33 Add : 16% Retailer Margin 1.01 Retail Price (without local taxes) 7.34 % Reduction with compared to Highest Price 17.36% S. TOTAL MAT 20,72,70, % Minimumum Price 4.54 Maximum Price 7.66 Average of all considered 6.33 Retail Price 7.34 Unit Considered 1 NICOFER XT 100/1.5/22.5 MG TABLET 10 NICOFER XT ABBOTT HEALTHCARE PVT. LTD 100/1.5/22.5 MG 10 TABLET ,64, % Y HUNTRED Z 100/1.5/22.5 MG TABLET 10 HUNTRED Z AKESISS PHARMA (P) LTD 100/1.5/22.5 MG 10 TABLET ,88,14, % Y IUP 100/1.5/22.5 MG TABLET 10 IUP CACHET PHARMACEUTICALS PVT LTD 100/1.5/22.5 MG 10 TABLET ,86,60, % Y DOCOFER 100/1.5/22.5 MG TABLET 10 DOCOFER GODDRES PHARMACEUTICALS LTD 100/1.5/22.5 MG 10 TABLET ,96, % Y MYMIFER 100/1.5/22.5 MG TABLET 10 MYMIFER HBC LIFESCIENCES PVT LTD 100/1.5/22.5 MG 10 TABLET ,90, % Y FERRO ATE 100/1.5/22.5 MG TABLET 10 FERRO ATE LUPIN LTD 100/1.5/22.5 MG 10 TABLET ,61, % N FERBIN Z 100/1.5/22.5 MG TABLET 10 FERBIN Z MAGNACHEM PHARMACEUTICALS PVT.LTD 100/1.5/22.5 MG 10 TABLET ,97, % N FERIKIND Z 100/1.5/22.5 MG TABLET 10 FERIKIND Z MANKIND PHARMACEUTICALS LTD. 100/1.5/22.5 MG 10 TABLET ,31,02, % Y LIVOGEN XT 100/1.5/22.5 MG TABLET 10 LIVOGEN XT MERCK LTD 100/1.5/22.5 MG 10 TABLET ,81,17, % Y NELOFAR AC 100/1.5/22.5 MG TABLET 10 NELOFAR AC NEURON PHARMA (P) LTD 100/1.5/22.5 MG 10 TABLET ,03, % N ASCAFERZ 100/1.5/22.5 MG TABLET 10 ASCAFERZ PULSE PHARMACEUTICALS PVT LTD 100/1.5/22.5 MG 10 TABLET ,25, % N HERFEM 100/1.5/22.5 MG TABLET 10 HERFEM TORRENT PHARMACEUTICALS LTD. 100/1.5/22.5 MG 10 TABLET ,33, % Y HEMOBEST XT 100/1.5/22.5 MG TABLET 10 HEMOBEST XT TTK HEALTHCARE LTD 100/1.5/22.5 MG 10 TABLET ,92,15, % Y FEVIPRO XT 100/1.5/22.5 MG TABLET 10 FEVIPRO XT TYCOON PHARMACEUTICALS PVT LTD 100/1.5/22.5 MG 10 TABLET ,87, % N 5.72 Rs. Per 10 Tablets Worked out Retail Price Claimed Retail Price Already notified Retail Price Proposed Retail Price 71.17

5 Computataion of Retail Price based on Feb., 2016 Data under Para 4 of DPCO 2013 OLMESARTAN 40mg + HYDROCLORTHIAZIDE 12.5mg Tablet of M/s Indu Drugs Pvt. Ltd. / M/s Kardian Pharma (I) Pvt. Ltd. Number of Companies cosisting of Market Share of 1% & Above 18 Sum of MAT value considered for price calculation (in Lakhs) Sum of PTR per unit considered for price calculation Number of s considered 22 Average PTR Add : 16% Retailer Margin 1.87 Retail Price (without local taxes) % Reduction with compared to Highest Price 29.27% S. TOTAL MAT 87,82,12, % Minimumum Price 5.41 Maximum Price Average of all considered Retail Price Levelwise MAT (ignoring O% MAT) 1 WIN BP H 40/12.5 MG TABLET 10 WIN BP H ABBOTT HEALTHCARE PVT. LTD 40/12.5 MG 10 TABLET ,90,15, % 2.17% Y OLKEM H 40/12.5 MG TABLET 14 OLKEM H ALKEM LABORATORIES LTD. 40/12.5 MG 14 TABLET ,95,59, % 3.61% Y OLKEM H 40/12.5 MG TABLET 15 OLKEM H ALKEM LABORATORIES LTD. 40/12.5 MG 15 TABLET ,22, % 3.61% Y OLMESAFE H 40/12.5 MG TABLET 10 OLMESAFE H ARISTO PHARMACEUTICALS PVT.LTD 40/12.5 MG 10 TABLET ,74, % 0.74% N OLWAYS H 40/12.5 MG TABLET 10 OLWAYS H ASTRAZENECA PHARMA INDIA LTD 40/12.5 MG 10 TABLET ,77, % 0.13% N OLMEBLU H 40/12.5 MG TABLET 10 OLMEBLU H BLUE CROSS LABORATORIES LTD 40/12.5 MG 10 TABLET ,53, % 0.29% N OLMECIP H 40/12.5 MG TABLET 10 OLMECIP H CIPLA LTD. 40/12.5 MG 10 TABLET ,27,29, % 1.45% Y OLSERTAIN H 40/12.5 MG TABLET 10 OLSERTAIN H DR. REDDYS LABORATORIES LTD 40/12.5 MG 10 TABLET ,88,14, % 5.30% Y OLSERTAIN H ACTIVE 40/12.5 MG TABLET 30 OLSERTAIN H ACTIVE DR. REDDYS LABORATORIES LTD 40/12.5 MG 30 TABLET ,41, % 5.30% Y OLMEGARD H 40/12.5 MG TABLET 10 OLMEGARD H EMCURE PHARMACEUTICALS LTD 40/12.5 MG 10 TABLET ,35, % 0.36% N OLMIN H 40/12.5 MG TABLET 10 OLMIN H ERIS LIFE SCIENCES PVT LTD 40/12.5 MG 10 TABLET ,80,68, % 4.33% Y OLMEFIT H 40/12.5 MG TABLET 10 OLMEFIT H FIDELITY LIFESCIENCE 40/12.5 MG 10 TABLET ,84, % 0.02% N BENITEC H 40/12.5 MG TABLET 7 BENITEC H GLAXOSMITHKLINE PHARMACEUTICALS LTD. 40/12.5 MG 7 TABLET ,39,19, % 2.72% Y OLMAX H 40/12.5 MG TABLET 10 OLMAX H GLENMARK PHARMACEUTICALS LTD. 40/12.5 MG 10 TABLET ,29, % 3.05% Y OLMAX H 40/12.5 MG TABLET 15 OLMAX H GLENMARK PHARMACEUTICALS LTD. 40/12.5 MG 15 TABLET ,16,81, % 3.05% Y OLMECROS H 40/12.5 MG TABLET 10 OLMECROS H GOLD LINE 40/12.5 MG 10 TABLET ,31, % 0.04% N OLMARK-H 40/12.5 MG TABLET 10 OLMARK-H INTAS PHARMACEUTICALS LTD 40/12.5 MG 10 TABLET ,26,03, % 3.71% Y OLMEGLARE H 40/12.5 MG TABLET 10 OLMEGLARE H IPCA LABORATORIES PVT LTD. 40/12.5 MG 10 TABLET ,94, % 0.43% N PINOM-H 40/12.5 MG TABLET 10 PINOM-H LUPIN LTD 40/12.5 MG 10 TABLET ,17,93, % 7.04% Y OLMESAR-H 40/12.5 MG TABLET 10 OLMESAR-H MACLEODS PHARMACEUTICALS PVT.LTD 40/12.5 MG 10 TABLET ,97,62, % 14.78% Y OLMETIME H 40/12.5 MG TABLET 10 OLMETIME H MANKIND PHARMACEUTICALS LTD. 40/12.5 MG 10 TABLET ,38,89, % 1.58% Y OLMIGHTY H 40/12.5 MG TABLET 10 OLMIGHTY H MERCK LTD 40/12.5 MG 10 TABLET ,45,39, % 1.66% Y OLMAT H 40/12.5 MG TABLET 10 OLMAT H MICRO LABS LTD 40/12.5 MG 10 TABLET ,97,41, % 6.80% Y OLSAVAS H 40/12.5 MG TABLET 10 OLSAVAS H ORCHID CHEMICALS & PHARMACEUTICALS LTD 40/12.5 MG 10 TABLET , % 0.01% N OLMEFLEX H 40/12.5 MG TABLET 10 OLMEFLEX H PRIMUS REMEDIES PVT LTD 40/12.5 MG 10 TABLET ,69, % 0.08% N OLRAAS H 40/12.5 MG TABLET 10 OLRAAS H RPG LIFE SCIENCES LTD. 40/12.5 MG 10 TABLET ,69, % 0.03% N OLVANCE H 40/12.5 MG TABLET 10 OLVANCE H SUN PHARMA LABS LTD. (Ranbaxy Lab. Ltd.) 40/12.5 MG 10 TABLET ,86,86, % 23.28% Y OLMEZEST H 40/12.5 MG TABLET 10 OLMEZEST H SUN PHARMA LABS LTD. (Ranbaxy Lab. Ltd.) 40/12.5 MG 10 TABLET ,57,61, % 23.28% Y OLMETOR H 40/12.5 MG TABLET 10 OLMETOR H TORRENT PHARMACEUTICALS LTD. 40/12.5 MG 10 TABLET ,69,06, % 1.93% Y OLSAR H 40/12.5 MG TABLET 10 OLSAR H UNICHEM LABORATORIES LTD 40/12.5 MG 10 TABLET ,47,78, % 5.10% Y OLMETRACK H 40/12.5 MG TABLET 10 OLMETRACK H USV LTD 40/12.5 MG 10 TABLET ,23,38, % 3.68% Y OLMY H 40/12.5 MG TABLET 10 OLMY H ZYDUS CADILA 40/12.5 MG 10 TABLET ,99,42, % 5.69% Y Rs. Per Tablet Worked out Retail Price Claimed Retail Price Already notified Retail Price Proposed Retail Price ( ) Unit Considered

6 Computataion of Retail Price based on Feb., 2016 Data under Para 4 of DPCO 2013 HUMAN CHORIONIC GONADOTROPIN 2000 IU Inj. of M/s Sanzyme (P) Ltd. / M/s Sandoz Pvt. Ltd. Number of Companies cosisting of Market Share of 1% & Above 8 Sum of MAT value considered for price calculation (in Lakhs) Sum of PTR per unit considered for price calculation Number of s considered 15 Average PTR Add : 16% Retailer Margin Retail Price (without local taxes) % Reduction with compared to Highest Price 26.23% TOTAL MAT 15,27,14, % Minimumum Price Maximum Price Average of all considered Retail Price Levelwise MAT (ignoring O% MAT) ( ) Unit Considered 1 OVIGYN 2000 IU INJECTION 1 ML OVIGYN ALEMBIC LTD 2000 IU 1 Each Vial ,29, % 0.28% N HUCOG HP 2000 IU INJECTION 1 HUCOG HP BHARAT SERUMS & VACCINES LTD 2000 IU 1 Each Vial ,22,97, % 27.70% Y OVUNAL-SC 2000 IU INJECTION 2 ML OVUNAL-SC INTAS PHARMACEUTICALS LTD 2000 IU 1 Each Vial , % 0.02% N LUPI-HCG 2000 IU INJECTION 1 LUPI-HCG LUPIN LTD 2000 IU 1 Each Vial ,81,58, % 18.44% Y MY HCG 2000 IU INJECTION 1 MY HCG MYLAN 2000 IU 1 Each Vial ,24, % 0.08% N NEO HCG 2000 IU INJECTION 1 ML NEO HCG NEON LABORATORIES LTD 2000 IU 1 Each Vial , % 0.02% N EUTRIG HP 2000 IU INJECTION 1 EUTRIG HP SAMARTH LIFE SCIENCES PVT LTD 2000 IU 1 Each Vial ,89, % 3.66% Y LUTIGEN GOLD 2000 IU INJECTION 1 ML LUTIGEN GOLD SANZYME LTD 2000 IU 1 Each Vial , % 11.44% Y ORIGEN 2000 IU INJECTION 1 ORIGEN SANZYME LTD 2000 IU 1 Each Vial ,20, % 11.44% Y PUBERGEN 2000 IU INJECTION 1 ML PUBERGEN SANZYME LTD 2000 IU 1 Each Vial ,41,28, % 11.44% Y PUBERGEN HP 2000 IU INJECTION 1 PUBERGEN HP SANZYME LTD 2000 IU 1 Each Vial ,15, % 11.44% Y SIFASI HP 2000 IU INJECTION 1 ML SIFASI HP SERUM INSTITUTE OF INDIA LTD 2000 IU 1 Each Vial ,52,89, % 10.01% Y FERTIGYN 2000 IU INJECTION 1 FERTIGYN SUN PHARMA LABORATORIES LTD IU 1 Each Vial ,12, % 12.50% Y FERTIGYN HP IU INJECTION 1 FERTIGYN HP-2000 SUN PHARMA LABORATORIES LTD IU 1 Each Vial ,40,73, % 12.50% Y OVUTRIG HP 2000 IU INJECTION 1 ML OVUTRIG HP VHB LIFE SCIENCES INC 2000 IU 1 Each Vial ,32,55, % 8.68% Y CORION 2000 IU INJECTION 1 ML CORION WIN-MEDICARE PVT. LTD IU 1 Each Vial ,79, % 0.44% N HCG 2000 IU INJECTION 1 HCG ZYDUS CADILA 2000 IU 1 Each Vial , % 6.73% Y OVIDAC 2000 IU INJECTION 2 ML OVIDAC ZYDUS CADILA 2000 IU 1 Each Vial ,19, % 6.73% Y ZYHCG 2000 IU INJECTION 1 ZYHCG ZYDUS CADILA 2000 IU 1 Each Vial ,86, % 6.73% Y ZYHCG HP 2000 IU INJECTION 1 ZYHCG HP ZYDUS CADILA 2000 IU 1 Each Vial ,31, % 6.73% Y Rs. Per Vial Worked out Retail Price Claimed Retail Price Already notified Retail Price - Proposed Retail Price

7 Computataion of Retail Price based on Feb., 2016 Data under Para 6 of DPCO 2013 Nevirapine ER Tablet 400mg of M/s Emcure Pharmaceuticals Ltd Number of Companies cosisting of Market Share of 1% & Above 1 Sum of MAT value considered for price calculation (in Lakhs) 4.99 Sum of PTR per unit considered for price calculation Number of s considered 1 Average PTR Add : 16% Retailer Margin 2.93 Retail Price (without local taxes) % Reduction with compared to Highest Price 0.00% TOTAL MAT 4,98, % Levelwise MAT (ignoring O% MAT) Minimumum Price Maximum Price Average of all considered Retail Price ( ) Unit Considered 1 NEVIMUNE XR 400 MG TABLET 10 NEVIMUNE CIPLA LTD. 400 MG 10 TABLET % % Y Rs. Per Tablet Worked out Retail Price Claimed Retail Price Already notified Retail Price - Proposed Retail Price 21.22

8 ड प स ओ 2013 क प र 4 क तहत, अगस त 2015 क आ कड क आध ररत, म ल य क स गणन Computation of Ceiling Price based on Aug-2015 Data under Para 4 of DPCO 2013 Number of Companies consisting of Market Share of 1% & Above Dobutamine Injection 50mg/ml Each Sum of MAT value considered for price calculation (in Lakhs) Sum of PTR per unit considered for price calculation Number of s considered 5 Average PTR Add : 16% Retailer Margin 4.93 Ceiling Price (without local taxes) (wef ) % Reduction with compared to Highest Price 44.78% WPI Reduction wef % 0.97 Final Ceiling Price (without local taxes) (wef or date of notification, whichever is later) Unique as per NLEM Composition as per NLEM Minimum Price 6.36 S.O. 619(E) dated Maximum Price Ceiling Price as per NLEM Each Average of all considered Derived PTR Ceiling Price TOTAL MAT 3,11,79, % DOBUTAMINE C1C5 DOTAMIN 250 MG INJECTION 5 ML DOTAMIN NEON LABORATORIES LTD 50 MG/ML 5 Each ,11, % Y DOBUTAMINE C1C5 DOTAMIN LYO 250 MG INJECTION 5 ML DOTAMIN LYO NEON LABORATORIES LTD 50 MG/ML 5 Each ,00, % Y DOBUTAMINE C1C5 DOBUSTAT 250 MG INJECTION 5 ML DOBUSTAT SAMARTH LIFE SCIENCES PVT LTD 50 MG/ML 5 Each ,20, % Y DOBUTAMINE C1C5 DOBUSOL 250 MG INJECTION 5 ML DOBUSOL UNITED BIOTECH (P) LTD 50 MG/ML 5 Each ,14, % N DOBUTAMINE C1C5 DOBUTAM 250 MG INJECTION 5 ML DOBUTAM UNITED BIOTECH (P) LTD 50 MG/ML 5 Each ,88, % Y DOBUTAMINE C1C5 DOBURAN 250 MG INJECTION 5 ML DOBURAN VHB LIFE SCIENCES INC 50 MG/ML 5 Each ,70, % N 6.60 DOBUTAMINE C1C5 DOBUCIN 250 MG INJECTION 5 ML DOBUCIN TROIKAA PHARMACEUTICALS LTD 50 MG/ML 5 Each ,07,73, % Y Considered

9 ड प स ओ 2013 क प र 4 क तहत, अगस त 2015 क आ कड क आध ररत, म ल य क स गणन Computation of Ceiling Price based on Aug-2015 Data under Para 4 of DPCO 2013 Number of Companies consisting of Market Share of 1% & Above Dopamine Injection 40mg/ml Per ML Sum of MAT value considered for price calculation (in Lakhs) Sum of PTR per unit considered for price calculation Number of s considered 6 Average PTR 4.45 Add : 16% Retailer Margin 0.71 Ceiling Price (without local taxes) (wef ) 5.16 % Reduction with compared to Highest Price 15.56% WPI Reduction wef % 0.14 Final Ceiling Price (without local taxes) (wef or date of notification, whichever is later) 5.02 Unique as per NLEM Composition as per NLEM Minimum Price 2.20 S.O. 619(E) dated Maximum Price 5.27 Ceiling Price as per NLEM Per ML Average of all considered 4.45 Derived PTR 5.27 Ceiling Price 5.16 TOTAL MAT 1,24,86, % DOPAMINE C1C7 DOPAGLAN 200 MG INJECTION 5 ML DOPAGLAN GLAND PHARMA LIMITED 40 MG/ML 5 ML ,25, % Y DOPAMINE C1C7 DOMIN (NEON LABS) 200 MG INJECTION 5 ML DOMIN (NEON LABS) NEON LABORATORIES LTD 40 MG/ML 5 ML ,85, % Y DOPAMINE C1C7 DOPAMINE 200 MG INJECTION 5 ML DOPAMINE SWISS PHARMA PVT. LTD 40 MG/ML 5 ML , % N DOPAMINE C1C7 DOPRESS 200 MG INJECTION 5 ML DOPRESS UNITED BIOTECH (P) LTD 40 MG/ML 5 ML ,51, % Y DOPAMINE C1C7 DOPAPLUS 200 MG INJECTION 5 ML DOPAPLUS VHB LIFE SCIENCES INC 40 MG/ML 5 ML , % N DOPAMINE C1C7 DOPACIN 40 MG/ML INJECTION 5 ML DOPACIN TROIKAA PHARMACEUTICALS LTD 40 MG/ML 5 ML ,29, % Y DOPAMINE C1C7 DOPAMINE ( TROIKAA) 40 MG/ML INJECTION 5 ML X 5 DOPAMINE ( TROIKAA) TROIKAA PHARMACEUTICALS LTD 40 MG/ML 25 ML ,85, % Y DOPAMINE C1C7 DOPAMINE (TTK) 40 MG/ML INJECTION 5 ML DOPAMINE (TTK) TTK HEALTHCARE LTD 40 MG/ML 5 ML ,41, % Y Unit Considered

10 Unique as per NLEM ड प स ओ 2013 क प र 4 क तहत, अगस त 2015 क आ कड क आध ररत, म ल य क स गणन Computation of Ceiling Price based on Aug-2015 Data under Para 4 of DPCO 2013 Number of Companies consisting of Market Share of 1% & Above Atracurium Injection 10 mg/ml Each Sum of MAT value considered for price calculation (in Lakhs) Sum of PTR per unit considered for price calculation Number of s considered 4 Average PTR Add : 16% Retailer Margin 6.89 Ceiling Price (without local taxes) (wef ) % Reduction with compared to Highest Price 0.00% WPI Reduction wef % 1.35 Final Ceiling Price (without local taxes) (wef or date of notification, whichever is later) Composition as per NLEM Minimum Price S.O. 619(E) dated Maximum Price Ceiling Price as per NLEM Each Average of all considered Derived PTR Ceiling Price TOTAL MAT 2,12,12, % ATRACURIUM M3A2 ACRIS 10 MG INJECTION 2.5 ML ACRIS GLAND PHARMA LIMITED 10 MG 1 Each ,83, % Y ATRACURIUM M3A2 ARTACIL 10 MG INJECTION 5 ML ARTACIL NEON LABORATORIES LTD 10 MG 1 Each ,24, % Y ATRACURIUM M3A2 ATCURON 10 MG INJECTION 2.5 ML ATCURON SUN PHARMA LABORATORIES LTD. 10 MG 1 Each ,33, % Y ATRACURIUM M3A2 TROYCURIUM 10 MG INJECTION 2.5 ML TROYCURIUM TROIKAA PHARMACEUTICALS LTD 10 MG 1 Each ,69, % Y Unit Considered

11 ड प स ओ 2013 क प र 4 क तहत, अगस त 2015 क आ कड क आध ररत, म ल य क स गणन Computation of Ceiling Price based on Aug-2015 Data under Para 4 of DPCO 2013 Number of Companies consisting of Market Share of 1% & Above Neostigmine Injection 0.5 mg/ml Per ML Sum of MAT value considered for price calculation (in Lakhs) Sum of PTR per unit considered for price calculation Number of s considered 3 Average PTR 3.58 Add : 16% Retailer Margin 0.57 Ceiling Price (without local taxes) (wef ) 4.15 % Reduction with compared to Highest Price 7.01% WPI Reduction wef % 0.11 Final Ceiling Price (without local taxes) (wef or date of notification, whichever is later) 4.04 Unique Composition as per NLEM as per NLEM Minimum Price 3.40 S.O. 619(E) dated Maximum Price 3.85 Ceiling Price as per NLEM Per ML Average of all considered 3.58 Derived PTR 3.85 Ceiling Price 4.15 TOTAL MAT 35,86, % Unit Unit Considered NEOSTIGMINE N7C10 MYOSTIGMIN 0.5 MG INJECTION 1 ML MYOSTIGMIN NEON LABORATORIES LTD 0.5 MG 1 ML ,05, % Y NEOSTIGMINE N7C10 TILSTIGMIN 0.5 MG INJECTION 5 ML TILSTIGMIN TABLETS INDIA LTD 0.5 MG 5 ML ,28, % Y NEOSTIGMINE N7C10 TILSTIGMIN 0.5 MG INJECTION 1 ML TILSTIGMIN TABLETS INDIA LTD 0.5 MG 1 ML ,52, % Y NEOSTIGMINE N7C10 NEOMINE 0.5 MG INJECTION 1 ML NEOMINE ZYDUS CADILA 0.5 MG 1 ML % N 6.37

12 ड प स ओ 2013 क प र 4 क तहत, अगस त 2015 क आ कड क आध ररत, म ल य क स गणन Computation of Ceiling Price based on Aug-2015 Data under Para 4 of DPCO 2013 Number of Companies consisting of Market Share of 1% & Above Anti-rabies immunoglobulin 150 IU/ML Per ML Sum of MAT value considered for price calculation (in Lakhs) Sum of PTR per unit considered for price calculation Number of s considered 3 Average PTR Add : 16% Retailer Margin Ceiling Price (without local taxes) (wef ) % Reduction with compared to Highest Price 40.62% WPI Reduction wef % Final Ceiling Price (without local taxes) (wef or date of notification, whichever is later) S. Unique Composition as per NLEM as per NLEM Minimum Price S.O. 839(E) dated Maximum Price Ceiling Price as per NLEM Per ML Average of all considered Derived PTR Ceiling Price TOTAL MAT 1,93,04, % ANTI RABIES SERA - IMMUNOGLOBULINS J6A6 BERIRAB P (BHARAT SERUMS) 300 IU INJECTION 2 ML BERIRAB P (BHARAT SERUMS) BHARAT SERUMS & VACCINES LTD 150 IU/ML 2 ML 2, ,72,04, % 89.12% Y ANTI RABIES SERA - IMMUNOGLOBULINS J6A6 BERIRAB P 300 IU INJECTION 2 ML BERIRAB P ZYDUS CADILA 150 IU/ML 2 ML 5, ,77, % 10.88% Y ANTI RABIES SERA - IMMUNOGLOBULINS J6A6 BERIRAB P 750 IU INJECTION 5 ML BERIRAB P ZYDUS CADILA 150 IU/ML 5 ML 4, , % 10.88% Y Levelwise MAT (ignoring O% MAT) ( ) Unit Considered